[go: up one dir, main page]

GB201914910D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB201914910D0
GB201914910D0 GB201914910A GB201914910A GB201914910D0 GB 201914910 D0 GB201914910 D0 GB 201914910D0 GB 201914910 A GB201914910 A GB 201914910A GB 201914910 A GB201914910 A GB 201914910A GB 201914910 D0 GB201914910 D0 GB 201914910D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201914910A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sentinel Oncology Ltd
Original Assignee
Sentinel Oncology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sentinel Oncology Ltd filed Critical Sentinel Oncology Ltd
Priority to GB201914910A priority Critical patent/GB201914910D0/en
Publication of GB201914910D0 publication Critical patent/GB201914910D0/en
Priority to PCT/EP2020/078960 priority patent/WO2021074251A1/en
Ceased legal-status Critical Current

Links

GB201914910A 2019-10-15 2019-10-15 Pharmaceutical compounds Ceased GB201914910D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB201914910A GB201914910D0 (en) 2019-10-15 2019-10-15 Pharmaceutical compounds
PCT/EP2020/078960 WO2021074251A1 (en) 2019-10-15 2020-10-14 Pyrrolo[2,3-d]pyrimidine derivatives and their use in the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201914910A GB201914910D0 (en) 2019-10-15 2019-10-15 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB201914910D0 true GB201914910D0 (en) 2019-11-27

Family

ID=68619675

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201914910A Ceased GB201914910D0 (en) 2019-10-15 2019-10-15 Pharmaceutical compounds

Country Status (2)

Country Link
GB (1) GB201914910D0 (en)
WO (1) WO2021074251A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117295743A (en) * 2021-04-30 2023-12-26 微境生物医药科技(上海)有限公司 Pyrrolopyrimidine derivatives as Wee-1 inhibitors
WO2022228509A1 (en) * 2021-04-30 2022-11-03 微境生物医药科技(上海)有限公司 Pyrrolopyrimidine derivative, preparation method therefor and use thereof
JP2024520969A (en) * 2021-05-28 2024-05-28 江蘇天士力帝益薬業有限公司 Wee1 inhibitors and their uses
WO2023030388A1 (en) * 2021-08-31 2023-03-09 微境生物医药科技(上海)有限公司 5-fluoro-7h-pyrrolo[2,3-d] pyrimidines compound as wee-1 inhibitor
TW202345806A (en) 2022-03-31 2023-12-01 美商艾伯維有限公司 Thiazolo[5,4-b]pyridine malt-1 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ587271A (en) * 2008-02-06 2012-03-30 Novartis Ag Pyrrolo[2,3-d]pyrimidines containing a 7h-pyrrolo[2,3-d]pyrimidin-2-yl core and use thereof as tyrosine kinase inhibitors
WO2015038417A1 (en) * 2013-09-10 2015-03-19 Asana Biosciences, Llc Compounds for regulating fak and/or src pathways
CN110691782A (en) * 2016-12-01 2020-01-14 艾普托斯生物科学公司 Fused pyrimidine compounds as dual inhibitors of BRD4 and JAK2 and methods of use
CN110467615A (en) * 2018-05-10 2019-11-19 四川科伦博泰生物医药股份有限公司 Azolopyrimidines include its pharmaceutical composition and its preparation method and application
CN111718348A (en) * 2019-03-22 2020-09-29 首药控股(北京)有限公司 WEE1 inhibitor, and preparation and application thereof

Also Published As

Publication number Publication date
WO2021074251A1 (en) 2021-04-22

Similar Documents

Publication Publication Date Title
GB201911928D0 (en) Pharmaceutical compounds
IL276232A (en) Pharmaceutical compounds
GB201800072D0 (en) Pharmaceutical
GB201800073D0 (en) Pharmaceutical
GB201810245D0 (en) Pharmaceutical compounds
GB201911944D0 (en) Pharmaceutical compounds
GB201810239D0 (en) Pharmaceutical compounds
GB201819961D0 (en) Pharmaceutical compounds
GB202020191D0 (en) Pharmaceutical compounds
GB201819960D0 (en) Pharmaceutical compounds
GB201915273D0 (en) Pharmaceutical compounds
GB201911517D0 (en) Pharmaceutical composition
GB201915932D0 (en) Pharmaceutical compounds
GB201914910D0 (en) Pharmaceutical compounds
GB202010408D0 (en) Pharmaceutical compounds
GB202010409D0 (en) Pharmaceutical compounds
GB201801562D0 (en) Pharmaceutical compounds
SI3908321T1 (en) Pharmaceutical composition
GB201901989D0 (en) Pharmaceutical combinations
IL291570A (en) Pharmaceutical compounds
GB201800378D0 (en) Pharmaceutical compounds
IL285728A (en) Pharmaceutical composition
GB202111193D0 (en) Pharmaceutical compounds
GB202104097D0 (en) Pharmaceutical compounds
SG11202110315SA (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)